Indivior Pharmaceuticals Inc (INDV) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Indivior Pharmaceuticals Inc (INDV) quarterly income statement — complete revenue, gross profit & net income history

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Sales/Revenue	317M	358M	314M	302M	266M	299M	307M	299M	284M	293M	271M	276M	253M	242M	232M	221M	207M	223M
Revenue Growth %	19.17%	19.73%	2.28%	1%	-6.34%	2.05%	13.28%	8.33%	12.25%	21.07%	16.81%	24.89%	22.22%	8.52%	-	-	-	-
Cost of Goods Sold	40M	64M	62M	52M	44M	23M	69M	79M	38M	51M	46M	50M	39M	44M	40M	38M	37M	39M
COGS % of Revenue	12.62%	17.88%	19.75%	17.22%	16.54%	7.69%	22.48%	26.42%	13.38%	17.41%	16.97%	18.12%	15.42%	18.18%	17.24%	17.19%	17.87%	17.49%
Gross Profit	277M	294M	252M	250M	222M	276M	238M	220M	246M	242M	225M	226M	214M	198M	192M	183M	170M	184M
Gross Margin %	87.38%	82.12%	80.25%	82.78%	83.46%	92.31%	77.52%	73.58%	86.62%	82.59%	83.03%	81.88%	84.58%	81.82%	82.76%	82.81%	82.13%	82.51%
Gross Profit Growth %	24.77%	6.52%	5.88%	13.64%	-9.76%	14.05%	5.78%	-2.65%	14.95%	22.22%	17.19%	23.5%	25.88%	7.61%	-	-	-	-
Operating Expenses	140M	172M	153M	178M	156M	180M	234M	338M	171M	181M	408M	165M	157M	456M	136M	120M	116M	139M
OpEx % of Revenue	44.16%	48.04%	48.73%	58.94%	58.65%	60.2%	76.22%	113.04%	60.21%	61.77%	150.55%	59.78%	62.06%	188.43%	58.62%	54.3%	56.04%	62.33%
Selling, General & Admin	124M	155M	133M	158M	132M	-47M	208M	152M	144M	157M	390M	133M	131M	432M	115M	109M	109M	136M
SG&A % of Revenue	39.12%	43.3%	42.36%	52.32%	49.62%	-15.72%	67.75%	50.84%	50.7%	53.58%	143.91%	48.19%	51.78%	178.51%	49.57%	49.32%	52.66%	60.99%
Research & Development	16M	17M	20M	21M	22M	31M	22M	26M	28M	29M	18M	32M	27M	29M	20M	14M	8M	19M
R&D % of Revenue	5.05%	4.75%	6.37%	6.95%	8.27%	10.37%	7.17%	8.7%	9.86%	9.9%	6.64%	11.59%	10.67%	11.98%	8.62%	6.33%	3.86%	8.52%
Other Operating Expenses	0	0	0	-1000K	1000K	1000K	1000K	1000K	-1000K	-1000K	0	0	-1000K	-1000K	1000K	-1000K	-1000K	-1000K
Operating Income	137M	122M	99M	72M	66M	96M	4M	-118M	75M	61M	-183M	61M	57M	-258M	56M	63M	54M	45M
Operating Margin %	43.22%	34.08%	31.53%	23.84%	24.81%	32.11%	1.3%	-39.46%	26.41%	20.82%	-67.53%	22.1%	22.53%	-106.61%	24.14%	28.51%	26.09%	20.18%
Operating Income Growth %	107.58%	27.08%	2375%	161.02%	-12%	57.38%	102.19%	-293.44%	31.58%	123.64%	-426.79%	-3.17%	5.56%	-673.33%	-	-	-	-
EBITDA	139M	127M	104M	77M	71M	101M	17M	-112M	80M	70M	-176M	67M	63M	-254M	62M	69M	59M	49M
EBITDA Margin %	43.85%	35.47%	33.12%	25.5%	26.69%	33.78%	5.54%	-37.46%	28.17%	23.89%	-64.94%	24.28%	24.9%	-104.96%	26.72%	31.22%	28.5%	21.97%
EBITDA Growth %	95.77%	25.74%	511.76%	168.75%	-11.25%	44.29%	109.66%	-267.16%	26.98%	127.56%	-383.87%	-2.9%	6.78%	-618.37%	-	-	-	-
D&A (Non-Cash Add-back)	2M	5M	5M	5M	5M	5M	13M	6M	5M	9M	7M	6M	6M	4M	6M	6M	5M	4M
EBIT	137M	122M	99M	77M	71M	101M	9M	-112M	82M	70M	-171M	72M	68M	-247M	62M	65M	54M	46M
Net Interest Income	-4M	0	-6M	-9M	-8M	-8M	-5M	-3M	-2M	1M	2M	1M	1M	3M	-2M	-5M	-6M	-6M
Interest Income	3M	6M	6M	6M	4M	5M	5M	6M	6M	10M	12M	11M	11M	11M	6M	2M	0	1M
Interest Expense	7M	6M	12M	15M	12M	13M	10M	9M	8M	9M	10M	10M	10M	8M	8M	7M	6M	7M
Other Income/Expense	-22M	-41M	-62M	-10M	-7M	-8M	-5M	-3M	-2M	1M	2M	1M	1M	3M	-2M	-5M	-6M	-5M
Pretax Income	115M	81M	37M	62M	59M	88M	-1M	-121M	73M	62M	-181M	62M	58M	-255M	54M	58M	48M	40M
Pretax Margin %	36.28%	22.63%	11.78%	20.53%	22.18%	29.43%	-0.33%	-40.47%	25.7%	21.16%	-66.79%	22.46%	22.92%	-105.37%	23.28%	26.24%	23.19%	17.94%
Income Tax	26M	-21M	-5M	44M	11M	28M	-5M	-23M	11M	8M	-46M	23M	14M	-72M	13M	10M	7M	4M
Effective Tax Rate %	22.61%	-25.93%	-13.51%	70.97%	18.64%	31.82%	500%	19.01%	15.07%	12.9%	25.41%	37.1%	24.14%	28.24%	24.07%	17.24%	14.58%	10%
Net Income	89M	102M	42M	18M	47M	59M	4M	-97M	61M	54M	-135M	39M	44M	-183M	41M	48M	41M	36M
Net Margin %	28.08%	28.49%	13.38%	5.96%	17.67%	19.73%	1.3%	-32.44%	21.48%	18.43%	-49.82%	14.13%	17.39%	-75.62%	17.67%	21.72%	19.81%	16.14%
Net Income Growth %	89.36%	72.88%	950%	118.56%	-22.95%	9.26%	102.96%	-348.72%	38.64%	129.51%	-429.27%	-18.75%	7.32%	-608.33%	-	-	-	-
Net Income (Continuing)	89M	102M	42M	18M	48M	60M	4M	-98M	62M	54M	-135M	39M	44M	-183M	41M	48M	41M	36M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	0.69	0.82	0.33	0.14	0.38	0.45	0.03	-0.72	0.45	0.38	-0.94	0.28	0.32	-1.38	0.27	0.33	0.27	0.25
EPS Growth %	81.58%	82.22%	1000%	119.44%	-15.56%	18.42%	103.19%	-357.14%	40.63%	127.54%	-448.15%	-15.15%	18.52%	-652%	-	-	-	-
EPS (Basic)	0.71	0.82	0.34	0.14	0.38	0.45	0.03	-0.72	0.45	0.39	-0.94	0.29	0.33	-1.38	0.28	0.33	0.29	0.25
Diluted Shares Outstanding	129M	125M	129M	123.68M	123.68M	128.08M	133.55M	134.85M	138.71M	141.95M	137.69M	142.73M	140.99M	136.48M	146.43M	139.68M	149M	140.49M
Basic Shares Outstanding	125.35M	125M	125M	123.68M	123.68M	126.61M	132.1M	134.85M	135.74M	137.32M	137.69M	138.1M	136.54M	136.48M	137.76M	139.68M	140.74M	140.49M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Indivior Pharmaceuticals Inc (INDV) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Indivior Pharmaceuticals Inc (INDV) quarterly income statement — complete revenue, gross profit & net income history

Annual Quarterly

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Sales/Revenue	317M	358M	314M	302M	266M	299M	307M	299M	284M	293M	271M	276M	253M	242M	232M	221M	207M	223M
Revenue Growth %	19.17%	19.73%	2.28%	1%	-6.34%	2.05%	13.28%	8.33%	12.25%	21.07%	16.81%	24.89%	22.22%	8.52%	-	-	-	-
Cost of Goods Sold	40M	64M	62M	52M	44M	23M	69M	79M	38M	51M	46M	50M	39M	44M	40M	38M	37M	39M
COGS % of Revenue	12.62%	17.88%	19.75%	17.22%	16.54%	7.69%	22.48%	26.42%	13.38%	17.41%	16.97%	18.12%	15.42%	18.18%	17.24%	17.19%	17.87%	17.49%
Gross Profit	277M	294M	252M	250M	222M	276M	238M	220M	246M	242M	225M	226M	214M	198M	192M	183M	170M	184M
Gross Margin %	87.38%	82.12%	80.25%	82.78%	83.46%	92.31%	77.52%	73.58%	86.62%	82.59%	83.03%	81.88%	84.58%	81.82%	82.76%	82.81%	82.13%	82.51%
Gross Profit Growth %	24.77%	6.52%	5.88%	13.64%	-9.76%	14.05%	5.78%	-2.65%	14.95%	22.22%	17.19%	23.5%	25.88%	7.61%	-	-	-	-
Operating Expenses	140M	172M	153M	178M	156M	180M	234M	338M	171M	181M	408M	165M	157M	456M	136M	120M	116M	139M
OpEx % of Revenue	44.16%	48.04%	48.73%	58.94%	58.65%	60.2%	76.22%	113.04%	60.21%	61.77%	150.55%	59.78%	62.06%	188.43%	58.62%	54.3%	56.04%	62.33%
Selling, General & Admin	124M	155M	133M	158M	132M	-47M	208M	152M	144M	157M	390M	133M	131M	432M	115M	109M	109M	136M
SG&A % of Revenue	39.12%	43.3%	42.36%	52.32%	49.62%	-15.72%	67.75%	50.84%	50.7%	53.58%	143.91%	48.19%	51.78%	178.51%	49.57%	49.32%	52.66%	60.99%
Research & Development	16M	17M	20M	21M	22M	31M	22M	26M	28M	29M	18M	32M	27M	29M	20M	14M	8M	19M
R&D % of Revenue	5.05%	4.75%	6.37%	6.95%	8.27%	10.37%	7.17%	8.7%	9.86%	9.9%	6.64%	11.59%	10.67%	11.98%	8.62%	6.33%	3.86%	8.52%
Other Operating Expenses	0	0	0	-1000K	1000K	1000K	1000K	1000K	-1000K	-1000K	0	0	-1000K	-1000K	1000K	-1000K	-1000K	-1000K
Operating Income	137M	122M	99M	72M	66M	96M	4M	-118M	75M	61M	-183M	61M	57M	-258M	56M	63M	54M	45M
Operating Margin %	43.22%	34.08%	31.53%	23.84%	24.81%	32.11%	1.3%	-39.46%	26.41%	20.82%	-67.53%	22.1%	22.53%	-106.61%	24.14%	28.51%	26.09%	20.18%
Operating Income Growth %	107.58%	27.08%	2375%	161.02%	-12%	57.38%	102.19%	-293.44%	31.58%	123.64%	-426.79%	-3.17%	5.56%	-673.33%	-	-	-	-
EBITDA	139M	127M	104M	77M	71M	101M	17M	-112M	80M	70M	-176M	67M	63M	-254M	62M	69M	59M	49M
EBITDA Margin %	43.85%	35.47%	33.12%	25.5%	26.69%	33.78%	5.54%	-37.46%	28.17%	23.89%	-64.94%	24.28%	24.9%	-104.96%	26.72%	31.22%	28.5%	21.97%
EBITDA Growth %	95.77%	25.74%	511.76%	168.75%	-11.25%	44.29%	109.66%	-267.16%	26.98%	127.56%	-383.87%	-2.9%	6.78%	-618.37%	-	-	-	-
D&A (Non-Cash Add-back)	2M	5M	5M	5M	5M	5M	13M	6M	5M	9M	7M	6M	6M	4M	6M	6M	5M	4M
EBIT	137M	122M	99M	77M	71M	101M	9M	-112M	82M	70M	-171M	72M	68M	-247M	62M	65M	54M	46M
Net Interest Income	-4M	0	-6M	-9M	-8M	-8M	-5M	-3M	-2M	1M	2M	1M	1M	3M	-2M	-5M	-6M	-6M
Interest Income	3M	6M	6M	6M	4M	5M	5M	6M	6M	10M	12M	11M	11M	11M	6M	2M	0	1M
Interest Expense	7M	6M	12M	15M	12M	13M	10M	9M	8M	9M	10M	10M	10M	8M	8M	7M	6M	7M
Other Income/Expense	-22M	-41M	-62M	-10M	-7M	-8M	-5M	-3M	-2M	1M	2M	1M	1M	3M	-2M	-5M	-6M	-5M
Pretax Income	115M	81M	37M	62M	59M	88M	-1M	-121M	73M	62M	-181M	62M	58M	-255M	54M	58M	48M	40M
Pretax Margin %	36.28%	22.63%	11.78%	20.53%	22.18%	29.43%	-0.33%	-40.47%	25.7%	21.16%	-66.79%	22.46%	22.92%	-105.37%	23.28%	26.24%	23.19%	17.94%
Income Tax	26M	-21M	-5M	44M	11M	28M	-5M	-23M	11M	8M	-46M	23M	14M	-72M	13M	10M	7M	4M
Effective Tax Rate %	22.61%	-25.93%	-13.51%	70.97%	18.64%	31.82%	500%	19.01%	15.07%	12.9%	25.41%	37.1%	24.14%	28.24%	24.07%	17.24%	14.58%	10%
Net Income	89M	102M	42M	18M	47M	59M	4M	-97M	61M	54M	-135M	39M	44M	-183M	41M	48M	41M	36M
Net Margin %	28.08%	28.49%	13.38%	5.96%	17.67%	19.73%	1.3%	-32.44%	21.48%	18.43%	-49.82%	14.13%	17.39%	-75.62%	17.67%	21.72%	19.81%	16.14%
Net Income Growth %	89.36%	72.88%	950%	118.56%	-22.95%	9.26%	102.96%	-348.72%	38.64%	129.51%	-429.27%	-18.75%	7.32%	-608.33%	-	-	-	-
Net Income (Continuing)	89M	102M	42M	18M	48M	60M	4M	-98M	62M	54M	-135M	39M	44M	-183M	41M	48M	41M	36M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	0.69	0.82	0.33	0.14	0.38	0.45	0.03	-0.72	0.45	0.38	-0.94	0.28	0.32	-1.38	0.27	0.33	0.27	0.25
EPS Growth %	81.58%	82.22%	1000%	119.44%	-15.56%	18.42%	103.19%	-357.14%	40.63%	127.54%	-448.15%	-15.15%	18.52%	-652%	-	-	-	-
EPS (Basic)	0.71	0.82	0.34	0.14	0.38	0.45	0.03	-0.72	0.45	0.39	-0.94	0.29	0.33	-1.38	0.28	0.33	0.29	0.25
Diluted Shares Outstanding	129M	125M	129M	123.68M	123.68M	128.08M	133.55M	134.85M	138.71M	141.95M	137.69M	142.73M	140.99M	136.48M	146.43M	139.68M	149M	140.49M
Basic Shares Outstanding	125.35M	125M	125M	123.68M	123.68M	126.61M	132.1M	134.85M	135.74M	137.32M	137.69M	138.1M	136.54M	136.48M	137.76M	139.68M	140.74M	140.49M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

INDV Income Statement

INDV Income Statement